Blueprint Medicines' Grant

Blueprint Medicines raised a round of funding on February 06, 2012. Investors include Massachusetts Life Sciences Center.

Blueprint Medicines is a patient-driven oncology company discovering and developing highly selective kinase inhibitors for genomically defined cancers. Led by a management team and advisors with world…

Articles about Blueprint Medicines' Grant: